Fighting Counterfeit Medicines in Europe: The Effect on Access to Medicines
The implementation of the Falsified Medicines Directive, and its Delegated Regulation with detailed specifications of safety features, will provide an additional obstacle for counterfeiters. The implementation of the Directive aims to prevent falsified medicines from reaching patients, and is in the...
Main Authors: | Maarten Van Baelen, Pieter Dylst, Catarina Lopes Pereira, Johan Verhaeghe, Koen Nauwelaerts, Susie Lyddon |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-01-01
|
Series: | Medicine Access @ Point of Care |
Online Access: | https://doi.org/10.5301/maapoc.0000010 |
Similar Items
-
Generic Medicine Pricing Policies in Europe: Current Status and Impact
by: Pieter Dylst, et al.
Published: (2010-03-01) -
Public health measures to fight counterfeit medicine market
by: Saurabh Ram BihariLal Shrivastava, et al.
Published: (2014-01-01) -
Adoption of Blockchain Technology in Pharmaceutical Supply Chain to fight Counterfeit Medicine Market
by: Shahzeb Zulfiqar, et al.
Published: (2022-12-01) -
Biosimilar medicines: creating sustainable competition in an era of a new patent cliff in biological medicines
by: Maarten Van Baelen
Published: (2015-12-01) -
Substandard and/or counterfeit medicines for patients
by: Subhash C Arya, et al.
Published: (2007-05-01)